Treatment of postoperative nausea and vomiting

BMJ 2003; 327 doi: http://dx.doi.org/10.1136/bmj.327.7418.762 (Published 2 October 2003)
Cite this as: BMJ 2003;327:762

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Martin R Tramèr (martin.tramer@hcuge.ch), consultant anaesthetist
  1. Division of Anaesthesiology, Department of Anaethesiology, Pharmacology, and Surgical Intensive Care, Geneva University Hospitals, CH-1211 Geneva 14, Switzerland

    Better data, improved control have been achieved during recent years

    Postoperative nausea and vomiting is a nuisance. The anaesthetist is usually blamed, despite evidence that postoperative nausea and vomiting results from several factors, some related to anaesthesia, others to surgery, and some to the patients themselves. The importance of postoperative nausea and vomiting is generally underestimated because it is self limiting, never becomes chronic, and almost never kills. However, its impact on the cost of health care is not negligible. Ten per cent of the population undergo general anaesthesia every year,1 and about 30% of them are affected by postoperative nausea and vomiting.2 This amounts to about two million people in the United Kingdom every year. About 1% of patients undergoing ambulatory surgery are admitted overnight because of uncontrolled postoperative nausea and vomiting.2

    Surgical patients prefer to suffer pain rather than postoperative nausea and vomiting3 and would be willing to pay considerable amounts of money for an effective antiemetic.4 However, successful control of postoperative nausea and vomiting has proved elusive. A major obstacle to the development of an effective treatment has been the lack of a valid animal model for postoperative nausea and vomiting. New insights into pathways for emesis and efficacy of antiemetics have come from animal research with highly emetogenic chemotherapy. Extrapolation of these data to postoperative nausea and vomiting has been of …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL